None
Quote | PreveCeutical Medical Inc (OTCMKTS:PRVCF)
Last: | $0.01624 |
---|---|
Change Percent: | 12.69% |
Open: | $0.01624 |
Close: | $0.01624 |
High: | $0.01624 |
Low: | $0.01624 |
Volume: | 2,000 |
Last Trade Date Time: | 04/23/2024 03:00:00 am |
News | PreveCeutical Medical Inc (OTCMKTS:PRVCF)
2023-12-04 10:00:34 ET %Obesity and diabetes have become a problem for developed world countries. To address the global rise of these issues, this company is pursuing a dual-gene therapy strategy using proprietary bionanotechnological approaches. The rational design of tissue-targeted b...
PREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES & OBESITY DUAL GENE THERAPY PROGRAM PREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES & OBESITY DUAL GENE THERAPY PROGRAM Canada NewsWire ...
Message Board Posts | PreveCeutical Medical Inc (OTCMKTS:PRVCF)
Subject | By | Source | When |
---|---|---|---|
$PRVCF PreveCeutical Initiates Non-Analgesic (Painkiller) Program, Clinical D | Louied91 | investorshub | 03/20/2023 11:53:39 AM |
louied91: $PRVCF PreveCeutical Initiates Non-Analgesic (Painkiller) Program, Clinical Development Pr | louied91 | investorshangout | 03/20/2023 11:53:38 AM |
Nice article posted today from Bezinga regarding $PREV | ZDSinvesting | investorshub | 02/16/2022 11:28:07 PM |
Great news today! Things are starting to fall | ZDSinvesting | investorshub | 01/14/2022 9:23:44 AM |
$BIG NEWS today! $PREV | ZDSinvesting | investorshub | 11/18/2021 8:50:11 PM |
News, Short Squeeze, Breakout and More Instantly...
PreveCeutical Medical Inc Company Name:
PRVCF Stock Symbol:
OTCMKTS Market:
2023-12-04 10:00:34 ET %Obesity and diabetes have become a problem for developed world countries. To address the global rise of these issues, this company is pursuing a dual-gene therapy strategy using proprietary bionanotechnological approaches. The rational design of tissue-targeted b...
PREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES & OBESITY DUAL GENE THERAPY PROGRAM PREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES & OBESITY DUAL GENE THERAPY PROGRAM Canada NewsWire ...
PreveCeutical Medical Inc (PRVCF) is expected to report for Q1 2024